Halozyme price target raised to $68 from $65 at H.C. Wainwright
The Fly

Halozyme price target raised to $68 from $65 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Halozyme (HALO) to $68 from $65 and keeps a Buy rating on the shares post the Q3 report. The company reported a “substantial” sales beat, driven by a jump in royalty revenues, the analyst tells investors in a research note.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App